BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37000259)

  • 21. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.
    Smyth EC; Wotherspoon A; Peckitt C; Gonzalez D; Hulkki-Wilson S; Eltahir Z; Fassan M; Rugge M; Valeri N; Okines A; Hewish M; Allum W; Stenning S; Nankivell M; Langley R; Cunningham D
    JAMA Oncol; 2017 Sep; 3(9):1197-1203. PubMed ID: 28241187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.
    Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J
    J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
    Miceli R; An J; Di Bartolomeo M; Morano F; Kim ST; Park SH; Choi MG; Lee JH; Raimondi A; Fucà G; Sohn TS; Bae JM; Kim S; Lim DH; Kang WK; Kim KM; Pietrantonio F; Lee J
    Oncology; 2019; 97(1):38-43. PubMed ID: 31048579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy.
    Gervaso L; Bottiglieri L; Meneses-Medina MI; Pellicori S; Biffi R; Fumagalli Romario U; De Pascale S; Sala I; Bagnardi V; Barberis M; Cella CA; Fazio N
    Clin Transl Oncol; 2023 Nov; 25(11):3287-3295. PubMed ID: 37084152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
    Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
    Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy.
    Du C; Zhao J; Xue W; Dou F; Gu J
    Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of telomere function in gastric cancers with and without microsatellite instability.
    Pascua I; Fernández-Marcelo T; Sánchez-Pernaute A; de Juan C; Head J; Torres-García AJ; Iniesta P
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):162-9. PubMed ID: 25486025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.
    Cai Z; Song H; Fingerhut A; Sun J; Ma J; Zhang L; Li S; Yu C; Zheng M; Zang L
    BMC Cancer; 2021 Mar; 21(1):319. PubMed ID: 33765970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients.
    Polom K; Marrelli D; Smyth EC; Voglino C; Roviello G; Pascale V; Varas J; Vindigni C; Roviello F
    Surg Innov; 2018 Apr; 25(2):99-104. PubMed ID: 29303062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
    Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
    Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma.
    Yashiro M; Inoue T; Nishioka N; Matsuoka T; Boland CR; Hirakawa K
    Ann Surg Oncol; 2009 Oct; 16(10):2926-35. PubMed ID: 19597886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer.
    Marrelli D; Polom K; Pascale V; Vindigni C; Piagnerelli R; De Franco L; Ferrara F; Roviello G; Garosi L; Petrioli R; Roviello F
    Ann Surg Oncol; 2016 Mar; 23(3):943-50. PubMed ID: 26530444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
    Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
    Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade.
    Randon G; Aoki Y; Cohen R; Provenzano L; Nasca V; Klempner SJ; Maron SB; Cerantola R; Chao J; Fornaro L; Ferrari Bravo W; Ghelardi F; Ambrosini M; Manca P; Salati M; Kawazoe A; Zhu V; Cowzer D; Genovesi V; Lonardi S; Shitara K; André T; Pietrantonio F
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37277193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.
    Yun S; Koh J; Nam SK; Kwak Y; Ahn SH; Do Park J; Kim HH; Kim WH; Lee HS
    Cancer Immunol Immunother; 2021 Feb; 70(2):431-441. PubMed ID: 32785776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of neoadjuvant chemotherapy on microsatellite instability in gastric carcinoma].
    Sun XW; Zhan YQ; Li W; Xu L; Li JT; Chen XJ; Zhang RH; Xu DZ
    Ai Zheng; 2006 Dec; 25(12):1493-6. PubMed ID: 17166373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
    Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
    Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
    Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite instability in Costa Rican patients with colorectal adenocarcinoma and its association with overall survival and response to fluoropyrimidine-based chemotherapy.
    Allan RE; Luis RP; Juan P
    Cancer Epidemiol; 2020 Apr; 65():101680. PubMed ID: 31986316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.